VYNE Therapeutics
VYNE
VYNE
33 hedge funds and large institutions have $18.4M invested in VYNE Therapeutics in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
44.91% more ownership
Funds ownership: 11.69% → 56.61% (+45%)
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.25M | |
| 2 | +$3.25M | |
| 3 | +$2.75M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.64M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.62M |
Top Sellers
| 1 | -$36K | |
| 2 | -$2.21K | |
| 3 | -$1.49K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$513 |